4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 4
Accession 0001415889-24-019908
CIK 0001817241other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 8:28 PM ET
Size
9.4 KB
Accession
0001415889-24-019908
Insider Transaction Report
Form 4
Transactions
- Conversion
Series B Preferred Stock
2024-07-22−145,089→ 0 total→ Common Stock (145,089 underlying) - Conversion
Common Stock
2024-07-22+145,089→ 145,089 total - Other
Common Stock
2024-07-22$10.20/sh+49,019$499,994→ 194,108 total
Footnotes (2)
- [F1]Each share of Series B Preferred Stock converted into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering (the "IPO"), the Series B Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Series B Preferred Stock had no expiration date.
- [F2]Represents the conversion of outstanding simple agreement for future equity in the amount of $500,000.00 into shares of the Issuer's common stock upon closing of the Issuer's IPO at a 15% discount to the IPO price.
Documents
Issuer
Artiva Biotherapeutics, Inc.
CIK 0001817241
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001787092
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 8:28 PM ET
- Size
- 9.4 KB